| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4185117 | European Psychiatry | 2008 | 4 Pages |
Abstract
Our data suggest that the occurrence of severe side-effects is relatively high with OXC. Measurement of plasma OXC levels does not appear to be of interest in clinical practice since plasma concentrations are not predictive of the occurrence of side effects.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
David Misdrahi, Marie Tournier, Tiphaine Droulout, Adeline Grolleau, Karine Titier, Mathieu Molimard, Helene Verdoux,